300267 爾康製藥
按盤價 
3.460 -0.070 (-1.983%)
3.460 -0.070 (-1.983%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.325 | -8.956 | -8.044 | -3.951 | 0.928 |
| 總資產報酬率 ROA (%) | 0.267 | -7.550 | -6.993 | -3.446 | 0.814 |
| 投入資產回報率 ROIC (%) | 0.275 | -7.798 | -7.235 | -3.606 | 0.856 | 邊際利潤分析 |
| 銷售毛利率 (%) | 28.426 | 26.444 | 27.523 | 20.424 | 22.220 |
| 營業利潤率 (%) | 4.147 | -31.313 | -32.521 | -11.593 | 0.737 |
| 息稅前利潤/營業總收入 (%) | 3.877 | -31.339 | -34.032 | -11.151 | 1.634 |
| 淨利潤/營業總收入 (%) | 3.812 | -34.253 | -34.453 | -12.442 | 1.982 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 59.468 | -0.375 | 19.107 | 56.875 | -66.062 |
| 價值變動淨收益/利潤總額(%) | 2.740 | 5.873 | 14.277 | 4.561 | 108.424 |
| 營業外收支淨額/利潤總額(%) | -0.205 | 0.756 | 4.511 | -3.917 | 20.596 | 償債能力分析 |
| 流動比率 (X) | 2.093 | 2.228 | 2.434 | 2.869 | 2.883 |
| 速動比率 (X) | 1.522 | 1.590 | 1.583 | 1.723 | 1.750 |
| 資產負債率 (%) | 20.167 | 18.247 | 15.338 | 12.211 | 13.740 |
| 帶息債務/全部投入資本 (%) | 14.915 | 12.275 | 10.043 | 7.075 | 7.715 |
| 股東權益/帶息債務 (%) | 558.890 | 700.051 | 877.575 | 1,295.790 | 1,177.652 |
| 股東權益/負債合計 (%) | 402.148 | 454.840 | 557.642 | 722.818 | 627.794 |
| 利息保障倍數 (X) | -14.803 | -147.599 | -1,336.839 | -2,082.766 | 2.314 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 45.513 | 34.614 | 33.538 | 24.515 | 30.811 |
| 存貨周轉天數 (天) | 263.273 | 233.588 | 281.647 | 191.927 | 190.048 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/06/2026 10:39 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
